These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12496064)

  • 1. Microsomal epoxide hydrolase variants are not associated with risk of breast cancer.
    de Assis S; Ambrosone CB; Wustrack S; Krishnan S; Freudenheim JL; Shields PG
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1697-8. PubMed ID: 12496064
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
    Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion.
    Wang X; Wang M; Niu T; Chen C; Xu X
    Epidemiology; 1998 Sep; 9(5):540-4. PubMed ID: 9730034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.
    Zheng W; Gao YT; Shu XO; Wen W; Cai Q; Dai Q; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):709-14. PubMed ID: 15159300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
    Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.
    Lancaster JM; Brownlee HA; Bell DA; Futreal PA; Marks JR; Berchuck A; Wiseman RW; Taylor JA
    Mol Carcinog; 1996 Nov; 17(3):160-2. PubMed ID: 8944076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
    Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
    Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer.
    Lacko M; Roelofs HM; Te Morsche RH; Voogd AC; Oude Ophuis MB; Peters WH; Manni JJ
    Head Neck; 2008 Jul; 30(7):836-44. PubMed ID: 18383527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.
    Lee SC; Hou MF; Hsieh PC; Wu SH; Hou LA; Ma H; Tsai SM; Tsai LY
    Clin Biochem; 2008 Feb; 41(3):121-5. PubMed ID: 18062925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
    Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.
    Huang WY; Chatterjee N; Chanock S; Dean M; Yeager M; Schoen RE; Hou LF; Berndt SI; Yadavalli S; Johnson CC; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):152-7. PubMed ID: 15668489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
    Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.